Vial Seal Integrity for Peptides: Inspection and Testing

Vial seal integrity for peptides is the ability of the assembled vial, stopper and crimp cap to keep moisture, oxygen and microorganisms out, and to hold the contents in, for the whole period between filling and use. Pharmacopoeial practice calls this container-closure integrity (CCI). A crimped aluminium cap does not guarantee it. Integrity is shown by a suitable test method, a defined leakage limit and sound receipt and storage controls. This article sets out how CCI is defined, which test methods apply to lyophilised peptide vials, which capping variables matter, and which checks a research laboratory in Australia can perform on receipt.

Aupeptidelabs

Source Research Peptides with Care

Au Peptide Labs supplies research peptides with purity testing and dispatches shipments from Australia within one business day.

View research peptides

What seal integrity covers, and what it does not

For sterile products, seal integrity is evaluated as a property of the whole package: the glass finish, the elastomeric stopper, the aluminium overseal and the capping process that joins them. The vial or the stopper considered in isolation is not the unit under assessment. In Australia, the manufacture of sterile medicines falls under the TGA's adoption of the PIC/S GMP framework. From 1 September 2025, version 17 of the PIC/S Guide applies, and the only changes from version 16 relate to Annex 1 on sterile manufacture. The TGA's PIC/S Guide page lists Annex 1 among the annexes of the earlier version.

The same literature draws a boundary that is often blurred in supplier marketing. Seal integrity does not establish peptide identity, purity, potency, sterility or endotoxin status. A 2025 review of therapeutic peptide characterisation states that a quality programme must characterise identity, purity and impurities, concentration, degradation products and, where relevant, bioactivity and microbiological attributes, and names ICH Q6B as a primary reference for specifications. It also notes that degradation products may have different, even opposite, biological activity from the intended peptide. A third-party purity certificate (COA) supports analytical release review, but it is not evidence of CCI, of validated storage conditions or of sterility assurance.

For that reason, two questions should be kept separate when a vial arrives:

Is the peptide what the certificate says it is? (an analytical question, addressed by the COA and, where needed, in-house verification)
Has the closure kept the contents dry, oxygen-limited and uncontaminated since filling? (a package-integrity question)

The first is covered in our guide to the three quality checks laboratories should verify on receipt. The second is the subject of the remainder of this article.

Why a leaking closure degrades a peptide

Lyophilised peptides are hygroscopic to varying degrees. NIBSC's guidance on peptide storage warns that moisture contamination can greatly reduce the long-term stability of solid peptides. Dry peptides are described there as stable at room temperature for days to weeks, while −20°C is preferred for long-term storage. A closure that admits water vapour therefore undermines the very property that makes a freeze-dried cake stable, regardless of the nominal HPLC purity recorded at release.

Three degradation routes are relevant to a compromised seal:

Moisture ingress, which accelerates hydrolysis and deamidation in susceptible sequences and can collapse the lyophilised cake.
Oxygen ingress, which affects residues prone to oxidation, such as methionine, cysteine and tryptophan.
Microbial ingress, which is a concern for any vial subsequently reconstituted and sampled more than once.

The mechanisms are sequence-dependent, and the rates depend on temperature, headspace composition and residual moisture at filling. For the relationship between water content and handling, see our overview of peptide hygroscopicity and the comparison of lyophilised and liquid formats for Australian laboratories.

Defining integrity: the maximum allowable leakage limit

A leak test has no meaning without a threshold. In CCI practice, the threshold is the maximum allowable leakage limit, defined for the specific product and package, not a universal number. The peer-reviewed holistic framework published by Fran DeGrazio in the PDA Journal argues that the leak-test instrument is only one part of the control strategy. Materials, test method, assembly process, personnel, environment and equipment must be assessed together, and the limit should be defined for the particular drug-package application.

Two practical consequences follow for laboratories:

A result of "no leak detected" is meaningful only relative to the sensitivity of the method used.
A figure quoted for one vial system (for example, a residual seal force or a leak rate) cannot be transferred to another stopper, vial or capper without qualification.

Test methods for lyophilised peptide vials

CCI methods are classed as probabilistic (for example, dye ingress or microbial challenge) or deterministic (for example, vacuum decay, helium leak and headspace analysis). Deterministic methods produce quantitative, reproducible data and are generally preferred where objective evidence is required. Visual inspection and dye-ingress screening remain useful as supporting tools, but they are less sensitive and more operator-dependent.

Method	Principle	Typical suitability for dry peptide vials	Main limitation
Visual inspection	Examination of crimp, stopper seating and glass	Screening on receipt	Cannot detect micro-leaks; subjective
Dye ingress	Vial immersed in dye under pressure or vacuum, then inspected	Qualitative, development work	Probabilistic; typically destructive
Vacuum decay	Sealed vial placed in a chamber; pressure rise after isolation indicates air ingress	Non-destructive, higher throughput for dry vials	Requires validated fixtures and defined limits
Helium leak detection	Tracer gas escaping a helium-filled vial is measured by a mass spectrometer	Highly sensitive; qualification and investigations	Specialised equipment; usually not a routine release test
High-voltage leak detection	Electrical conductivity across a defect	Liquid-filled conductive systems	Generally unsuited to dry lyophilised cakes
Headspace oxygen analysis	Laser-based measurement of oxygen in the vial headspace	Useful where cold storage is involved	Method must be qualified for the container

The table reflects the method comparison in the peptide CCI literature: helium leak testing is highly sensitive and suited to qualification, vacuum decay suits non-destructive testing of dry vials, and high-voltage detection is generally reserved for liquid-filled systems.

Most research laboratories will not operate a vacuum decay or helium instrument. The practical implication is that the assurance of CCI sits upstream, with the filler's validated capping and test programme, and downstream, with receipt inspection and storage discipline. A laboratory can reasonably ask a supplier what closure system is used and how it was qualified, while recognising that those answers are separate from a purity COA.

Capping variables that determine the seal

The seal is created at the capper. A stopper is compressed into the vial finish, and the aluminium overseal is crimped to hold that compression. Several variables act together.

Residual seal force is a process indicator, not a pass mark

Residual seal force (RSF) is the quantifiable force the crimped cap maintains on the stopper. A peer-reviewed study of capping equipment reported RSF values ranging from 7 to 115 N across tested settings, with higher values associated with greater pre-compression force and a shorter distance between capping plate and plunge. All of the tested vials nevertheless passed helium-leak CCI testing. The authors' data therefore show that RSF targets must be correlated with direct integrity data for the specific closure; the numerical range is not an acceptance criterion.

The simple rule that more crimp force means a better seal is unreliable. In a study by Ovadia and colleagues, component dimensional tolerances were the principal source of RSF variability in the tested configurations. A vial could retain CCI even with no measurable RSF when another stopper sealing surface remained functional, because the stopper can provide separate valve and land sealing surfaces.

Stopper geometry

In a PDA Journal reexamination using micro-computed tomography, serum stoppers consistently failed CCI below 15.8 N RSF, whereas lyophilisation stoppers were more robust. With the plug removed, both designs showed a critical lower limit of approximately 19 to 20 N. These values are specific to the configuration studied and must not be applied to another vial system without qualification.

The same work shows that apparent seal performance can change over time. Some previously failed vials passed on later testing, plausibly because rubber relaxation filled minor imperfections. Testing time points should therefore be defined, and a single delayed result should not be interpreted without knowing the closure configuration.

Cold storage and shipping change the picture

Room-temperature leak testing does not qualify a vial for frozen storage. Elastomer glass-transition behaviour and differing thermal expansion coefficients of glass, rubber and aluminium can create transient breaches at low temperature that reseal on warming. A 2024 PDA Journal study of cryogenic vials used laser-based headspace oxygen analysis and detected micron-sized positive controls down to 5 µm in vial bodies and at stopper interfaces after exposure at approximately −150°C to −190°C. That range is distinct from ordinary refrigeration or −20°C storage and should not be generalised to every peptide shipment. The practical conclusion is narrower: where a peptide programme uses −80°C or cryogenic conditions, the assembled system should be tested at the actual temperature profile, including shipment and thaw transitions.

For refrigerated consignments, see our notes on 2–8°C cold chain shipping and verification on arrival. Summer transit in Australia raises separate issues, addressed in the hot weather shipping checklist for powder and solution formats.

Receipt inspection: a practical sequence

A laboratory cannot measure CCI on a vial it intends to use, but it can detect gross failures and preserve the integrity that exists. The following sequence is consistent with NIBSC storage guidance and with the closure literature above.

Inspect the outer packaging for crushing, moisture or temperature indicator changes before opening.
Examine the crimp. The aluminium overseal should be fully formed, with no rotation under light finger pressure, no lifting at the skirt and no gaps.
Examine the stopper. Look for displacement, an inward-pushed stopper, visible tears or a stopper surface that appears wet or discoloured.
Examine the glass. Check the shoulder, base and finish for hairline cracks or chips that could breach the vacuum.
Inspect the cake. A lyophilised cake that has collapsed, shrunk away from the wall or turned glassy may indicate moisture exposure. Appearance alone is not a diagnostic, and the limits of this check are covered in peptide visual inspection: four red flags and one blind spot.
Reconcile documentation. Confirm that the lot number on the label matches the COA and the storage instructions.
Store promptly under the specified dry, cool, dark conditions. NIBSC prefers 4°C or colder for general preservation and −20°C for the long term.
Equilibrate before opening. Let the vial reach room temperature before the stopper is pierced or the cap removed, so that condensation does not enter.
Reseal after sampling, preferably under dry inert gas, as NIBSC advises.

Any vial that fails steps 2 to 4 should be quarantined, photographed and reported to the supplier, not used. A vial that has been dropped warrants the same inspection, with attention to a stopper shifted or pushed inward.

Reconstituted peptides and container material

Once a peptide is in solution, integrity concerns shift from the closure to the container surface and to handling. NIBSC notes that dilute peptide solutions can adsorb to vial surfaces. Glass and polypropylene can both be suitable, but compatibility depends on the solvent, the peptide concentration and adsorption behaviour. Low-concentration solutions are especially vulnerable to surface losses. Aliquoting under aseptic conditions limits repeated stopper punctures; our guide to aseptic bench handling with COA-verified aliquots and the checklist for 14-day sterility assessment aligned to USP and WHO cover this stage.

Where a COA fits alongside seal integrity

A COA reports analytical attributes of a lot, typically identity by mass spectrometry and purity by HPLC. It does not report whether a given vial's closure was leak-tight at dispatch or on arrival. Laboratories that read certificates carefully will therefore treat three layers as complementary: batch analytics, package integrity and storage history. A useful external reference on which COA tests establish which peptide quality attributes clarifies the attributes that need separate testing and that a seal inspection cannot replace. The packaging side is covered in our guide to peptide packaging materials for Australian laboratories, and verification of authenticity in the note on spotting counterfeit peptides in Australia.

Our perspective

Our perspective — overview diagram

We regard seal integrity as a variable that a supplier can influence only partly and a laboratory can degrade easily. What a supplier controls is the stability of the supply chain around the vial: third-party testing of each batch to 99%+ purity with a verifiable COA, domestic dispatch from Melbourne within one business day, and discreet packaging. Domestic dispatch means a consignment does not wait at customs, which shortens the period a vial spends in uncontrolled transit. We do not present a COA as evidence of CCI, and the literature cited above supports keeping those claims apart.

Our recommendation to research teams is procedural. Inspect the crimp and stopper at the bench on the day of receipt, record the lot against the certificate, move the vial into specified storage without delay, and allow equilibration before opening. A vial that passes these steps has not been proven leak-tight in the CCI sense, but the likelihood that a gross closure defect goes unnoticed falls markedly. All products we supply are for laboratory research only, not for human or veterinary use.

— Dr. Authur

Research supplies from Au Peptide Labs

Au Peptide Labs stocks research peptides across metabolic, recovery, growth hormone secretagogue, cognitive and longevity categories, with third-party purity certificates and dispatch from Melbourne. Laboratory consumables, including bacteriostatic water, insulin syringes and alcohol wipes, are available under Lab Supplies. Express Post is listed at $10 as a one-off fee, and the full catalogue and checkout are on the Au Peptide Labs store. Custom and bulk orders are available on request.

Frequently asked questions

Is a crimped aluminium cap enough to guarantee a sterile, sealed vial?

No. Integrity depends on the interaction of the glass finish, stopper, overseal and capping process, and it is demonstrated by a validated test against a defined leakage limit. A well-formed crimp is a necessary visual indicator, not proof.

Can a laboratory test vial seal integrity itself?

Quantitative methods such as vacuum decay and helium leak detection need specialised, qualified equipment. On receipt, a laboratory can perform visual checks of the crimp, stopper and glass, and can confirm lot and storage documentation. Suspect vials should be quarantined and referred to the supplier.

Does a 99% purity COA show that the seal was intact?

No. A purity certificate reports analytical attributes of the batch at the time of testing. It is not a substitute for CCI evidence, validated storage conditions or sterility assurance.

How should peptide vials be stored to protect stability?

NIBSC advises a dry, cool, dark place, with −20°C preferred for long-term storage of dry peptides. Allow the vial to reach room temperature before opening, and where possible reseal under dry inert gas after sampling.

Does a dropped vial need to be discarded?

Not automatically, but it needs inspection. Check the glass for hairline cracks, the crimp for deformation and the stopper for inward displacement. If any of these is present, the vacuum and sterility cannot be assumed and the vial should not be used.